JPY 1818.0
(0.83%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 37.75 Billion JPY | -0.04% |
2022 | 37.76 Billion JPY | 8.64% |
2021 | 34.76 Billion JPY | -2.38% |
2020 | 35.61 Billion JPY | 26.84% |
2019 | 28.07 Billion JPY | 30.48% |
2018 | 21.51 Billion JPY | 16.08% |
2017 | 18.53 Billion JPY | 3.13% |
2016 | 17.97 Billion JPY | 9.52% |
2015 | 16.41 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 39.33 Billion JPY | 4.19% |
2024 Q2 | 42.13 Billion JPY | 7.12% |
2023 Q3 | 39.01 Billion JPY | -2.14% |
2023 FY | 37.75 Billion JPY | -0.04% |
2023 Q1 | 38.17 Billion JPY | 1.07% |
2023 Q4 | 37.75 Billion JPY | -3.24% |
2023 Q2 | 39.87 Billion JPY | 4.45% |
2022 Q2 | 39.05 Billion JPY | 3.69% |
2022 FY | 37.76 Billion JPY | 8.64% |
2022 Q4 | 37.76 Billion JPY | -3.63% |
2022 Q3 | 39.19 Billion JPY | 0.35% |
2022 Q1 | 37.66 Billion JPY | 8.34% |
2021 Q1 | 37.24 Billion JPY | 4.59% |
2021 Q3 | 37.02 Billion JPY | -3.27% |
2021 FY | 34.76 Billion JPY | -2.38% |
2021 Q2 | 38.27 Billion JPY | 2.77% |
2021 Q4 | 34.76 Billion JPY | -6.11% |
2020 Q4 | 35.61 Billion JPY | -3.59% |
2020 Q2 | 34.96 Billion JPY | 17.72% |
2020 Q1 | 29.69 Billion JPY | 5.78% |
2020 FY | 35.61 Billion JPY | 26.84% |
2020 Q3 | 36.93 Billion JPY | 5.66% |
2019 Q3 | 27.75 Billion JPY | 0.0% |
2019 Q4 | 28.07 Billion JPY | 1.15% |
2019 FY | 28.07 Billion JPY | 30.48% |
2019 Q1 | 24.17 Billion JPY | 12.32% |
2018 Q1 | 21.64 Billion JPY | 0.0% |
2018 FY | 21.51 Billion JPY | 16.08% |
2018 Q4 | 21.51 Billion JPY | -5.84% |
2018 Q3 | 22.85 Billion JPY | 1.04% |
2018 Q2 | 22.61 Billion JPY | 4.51% |
2017 FY | 18.53 Billion JPY | 3.13% |
2016 FY | 17.97 Billion JPY | 9.52% |
2015 FY | 16.41 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
HEARTSEED INC | 450.19 Million JPY | -8286.2% |
Cawachi Limited | 85.94 Billion JPY | 56.07% |
Pharmarise Holdings Corporation | 22.09 Billion JPY | -70.84% |
Qol Holdings Co., Ltd. | 64.93 Billion JPY | 41.861% |
MatsukiyoCocokara & Co. | 209.56 Billion JPY | 81.985% |
Welcia Holdings Co., Ltd. | 307.48 Billion JPY | 87.722% |
Create SD Holdings Co., Ltd. | 86.23 Billion JPY | 56.22% |
NIHON CHOUZAI Co.,Ltd. | 136.73 Billion JPY | 72.388% |
COSMOS Pharmaceutical Corporation | 245.53 Billion JPY | 84.624% |
Tsuruha Holdings Inc. | 241.47 Billion JPY | 84.365% |
Ohki Healthcare Holdings Co.,Ltd. | 112.17 Billion JPY | 66.344% |
Satudora Holdings Co.,Ltd. | 35.89 Billion JPY | -5.167% |
Kusuri No Aoki Holdings Co., Ltd. | 186.03 Billion JPY | 79.705% |
Medical System Network Co., Ltd. | 52.97 Billion JPY | 28.73% |
Shinnihonseiyaku Co., Ltd. | 5.84 Billion JPY | -546.251% |
Sugi Holdings Co.,Ltd. | 158.62 Billion JPY | 76.199% |
Astena Holdings Co., Ltd. | 38.65 Billion JPY | 2.326% |
Genky DrugStores Co., Ltd. | 67.25 Billion JPY | 43.864% |
Ain Holdings Inc. | 113.99 Billion JPY | 66.881% |
Sundrug Co.,Ltd. | 168.21 Billion JPY | 77.556% |